Osteoarthritis Treatment & Management
- Author: Carlos J Lozada, MD; Chief Editor: Herbert S Diamond, MD more...
Approach Considerations
The goals of osteoarthritis treatment include pain alleviation and the improvement of functional status.[46]
Several treatment options are available for slowing or stopping the progression of this common disorder. Pharmacologic agents used in the treatment of osteoarthritis include the following:
- Corticosteroids
- Sodium Hyaluronate
- Acetaminophen
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Muscle relaxants
- Glucocorticoids
Nonpharmacologic interventions, which are the cornerstones of osteoarthritis therapy, include the following:
- Patient education
- Temperature-based modalities
- Weight loss[47]
- Exercise
- Physical therapy
- Occupational therapy
- Unloading in certain joints (eg, knee, hip)
Pharmacologic Treatment
The American College of Rheumatology issued the following pharmacologic guidelines for the treatment of osteoarthritis of the hip and knee:[48]
- Arthrocentesis with corticosteroid injection can be used only for knee osteoarthritis if effusion is present.
- Up to 4 g/d of acetaminophen can be administered. This is the preferred initial treatment for patients with osteoarthritis.
- Topical anti-inflammatory medications or capsaicin can be administered only for knee osteoarthritis.
- Low-dose nonsteroidal anti-inflammatory drugs (NSAIDs) (ie, analgesic doses) or nonacetylated salicylates may be indicated.
- Administer full-dose NSAIDs with misoprostol if risk factors for upper gastrointestinal bleeding are present.
- Narcotic analgesic use may be indicated in cases of severe pain.
Analgesics, NSAIDs, and COX-2 inhibitors
Begin treatment with acetaminophen for mild or moderate osteoarthritic pain without apparent inflammation. If the clinical response to acetaminophen is not satisfactory or if the clinical presentation of osteoarthritis is inflammatory, consider using nonsteroidal anti-inflammatory drugs (NSAIDs). Use the lowest effective dose or intermittent dosing if symptoms are intermittent and then try full doses if the patient's response is insufficient. In patients with highly resistant pain, consider the analgesic tramadol. Options in patients at an elevated risk for GI toxicity due to NSAIDs include the addition of a proton-pump inhibitor or misoprostol to the treatment regimen or the use of a selective cyclooxygenase (COX) inhibitor instead of the nonselective NSAID.
Corticosteroid injections
Intra-articular pharmacologic therapy includes corticosteroid injection and viscosupplementation, which may provide pain relief and have an anti-inflammatory effect on the affected joint.[49, 50] Radiologists may aid in the treatment of osteoarthritis by administering image-guided intra-articular injections of steroids.
After the introduction of the needle into the joint and prior to steroid administration, aspiration of as much synovial fluid as possible should be attempted. This procedure often provides symptomatic relief for the patient and allows laboratory evaluation of the fluid, if necessary. Infected joint fluid and bacteremia are contraindications to steroid injection.
Steroid injections generally result in a clinically and statistically significant reduction in osteoarthritic knee pain as soon as 1 week after injection. The effect may last, on average, anywhere from 4-6 weeks per injection, but this benefit is unlikely to continue beyond that time frame.[51]
One randomized, placebo-controlled study confirmed the effectiveness of corticosteroid injection in the treatment of hip osteoarthritis, with benefits often lasting as long as 3 months.[52] Some controversial evidence exists regarding frequent steroid injections and subsequent damage to cartilage (chondrodegeneration). Therefore, usually no more than 3 injections are recommended per year in any 1 osteoarthritic joint. Systemic glucocorticoids have no role in the management of osteoarthritis.
To see complete information on Injection, Acromioclavicular Joint, please go to the main article by clicking here.
Additional pharmacologic agents
Muscle relaxants may benefit patients with evidence of muscle spasm. Judicious use of narcotics (eg, acetaminophen with codeine; oxycodone) is reserved for patients with severe osteoarthritis.
Glucosamine and chondroitin sulfate, which are being studied by the National Institutes of Health (NIH) in double-blind trials, have been used in Europe for many years. Another agent, S-adenosylmethionine (SAM-e [pronounced "sammy"]), is a European supplement receiving a lot of attention in the United States.
Chondroprotective drugs (ie, matrix metalloproteinase [MMP] inhibitors, growth factors) are being tested as disease-modifying drugs in the management of osteoarthritis.[53]
Nonpharmacologic Treatment
Instruct the patient to avoid aggravating stress to the affected joint. Implement correction procedures if the patient illustrates poor posture. Lifestyle modification, particularly exercise and weight reduction, is a core component in the management of osteoarthritis (OA).[54, 55] Weight reduction relieves stress on the affected knees or hips. The benefits of weight loss, whether obtained through regular exercise and diet or surgical interventions, may extend not only to symptom relief but also to a slowing in cartilage loss in weight-bearing joints such as knees with radiographic OA.[56]
Osteoarthritis of the knee may result in disuse atrophy of the quadriceps. Because these muscles help to protect the articular cartilage from further stress, most research into osteoarthritis of the knee focuses on quadriceps strengthening in knee osteoarthritis. Stretching exercises are also important in the treatment of osteoarthritis, because they increase range of motion.
Some patients with osteoarthritis benefit from heat and capsaicin cream placed locally over the affected joint, and a minority of patients report relief with ice.[57]
For more information, see Surgical Treatment of Patellofemoral Arthritis and Surgical Treatment of Interphalangeal Joint Arthritis.
Physical Therapy
In a study of patients with knee osteoarthritis, Jan et al found that, in most respects, non–weight-bearing exercise was as therapeutically effective as weight-bearing exercise.[58] After an 8-week exercise program, patients in the weight-bearing and non–weight-bearing groups showed equally significant improvements in function, walking speed, and muscle torque. However, patients in the weight-bearing group demonstrated greater improvement in position sense, which may help patients with complex walking tasks, such as walking on a spongy surface.
Chaipinyo and Karoonsupcharoen found no significant difference between home-based strength training and home-based balance training for knee pain caused by osteoarthritis. However, more improvement was noted in the strength-training group in terms of knee-related quality of life.[59]
The importance of aerobic conditioning, particularly low-impact exercises (if osteoarthritis affects weight-bearing joints), should be stressed as well. Swimming, especially aerobic aquatic programs through the Arthritis Foundation, can be helpful.
Results from a study by Wang et al suggested that tai chi is a potentially effective treatment for pain associated with osteoarthritis of the knee.[60] In a prospective, single-blind, randomized, controlled trial, 40 patients with symptomatic tibiofemoral osteoarthritis who performed 60 minutes of tai chi twice weekly for 12 weeks experienced significantly greater pain reduction than did control subjects who underwent 12 weeks of wellness education and stretching. The mean difference in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain scores was -118.80 mm.
The tai chi cohort also had significantly better WOMAC physical function scores, patient and physician global visual analog scale scores, chair stand time, Center for Epidemiologic Studies Depression Scale scores, self-efficacy scores, and Short Form 36 physical component summaries.
In a review on patient adherence to exercise, Marks and Allegrante concluded that interventions to enhance self-efficacy, social support, and skills in the long-term monitoring of progress are necessary to foster exercise adherence in people with osteoarthritis.[61]
Assistive devices
The use of assistive devices for ambulation and for activities of daily living may be indicated for patients with osteoarthritis. Braces and appropriate footwear may also be of some use. A cane can be used in the opposite hand for hip osteoarthritis, and a cane in the hand of comfort may be helpful for knee osteoarthritis. The patient can be taught joint-protection and energy-conservation techniques. Other physical therapy modalities include electrotherapy and thermotherapy.
Patients who undergo arthroscopy (see below for surgical treatment options) usually require a period of crutch use and/or exercise therapy; this typically lasts days or sometimes weeks. Those patients undergoing osteotomy and fusion require partial weight bearing until bony healing occurs; afterward, exercise is indicated.
After joint replacement, patients require partial weight bearing, which progresses to full weight bearing in 1-3 months; range-of-motion and strengthening exercises are started within a few days after joint-replacement surgery and continued until the patient has good range of motion and strength. After resection arthroplasty of the hip, patients require instruction in the use of crutches or a walker, which are usually needed permanently.
Occupational therapy
Occupational adjustments may be necessary for some patients with osteoarthritis. Evaluation of how well the patient performs his/her activities of daily living, as well as retraining of the patient, can be assisted by an occupational therapist. Joint-protection techniques should be emphasized. Hand splinting, especially of the first carpometacarpal joint, may be indicated.
Sodium hyaluronate injections
In the United States, HAs are classified as medical devices rather than as drugs.[62] Although the exact mechanisms of action through which they provide symptomatic relief are unknown, several possibilities exist, including direct binding to receptors (CD44 in particular) in the synovium and cartilage that can lead to several biologic activation pathways. These mechanisms of action can include the following:
- Increased endogenous production of hyaluronate and aggrecan by the joint
- A mechanical barrier to the activation of nociceptors
- The inhibition of pain mediators (eg, PGE, bradykinin)
- An anti-inflammatory effect (eg, inhibition of proinflammatory cytokine activity, inhibition of inflammatory cell function)
- A beneficial effect on immune cells
- An antioxidant effect
- Restoration of the synovial fluid's physical characteristics (viscoelasticity)
Intra-articular injection of sodium hyaluronate (ie, hyaluronic acid [HA], hyaluronan), also referred to as viscosupplementation, has been shown to be safe and effective for the symptomatic relief of knee osteoarthritis.[63, 64]
Intra-articular HAs approved by the US Food and Drug Administration (FDA) for the treatment of osteoarthritic knee pain include the naturally extracted, non–cross-linked sodium hyaluronate products Hyalgan,[65] Supartz, Orthovisc, and Euflexxa and the cross-linked sodium hyaluronate product known as hylan G-F 20 (Synvisc). Euflexxa is derived from a fermentation process (Streptococcus), while the source material for the other products listed is chicken combs. At present, no distinct advantage or disadvantage has been associated with either source of HA.
Some differences between the viscosupplements do exist in the FDA-approved prescribing information. For example, Hyalgan and Synvisc have been established as safe for repeat treatment, while the safety and efficacy of other products for repeat treatment has not been established.
The HA class in general has demonstrated a very favorable safety profile for the chronic pain management of knee osteoarthritis, with the most common adverse event being injection site pain. While any intra-articular injection (HA products and steroids) may elicit an inflammatory response and possible effusion, a clinically distinct acute inflammatory side effect (ie, severe acute inflammatory reaction [SAIR] or HA–associated intra-articular pseudosepsis) has been described. However, preclinical and clinical data provide compelling evidence that this reaction is limited only to the cross-linked hylan G-F 20 product and may have an immunologic mechanism of action. Molecular weight per se has not been found to correlate with efficacy (eg, higher or lower viscosity does not equate with better or worse clinical outcomes).
Interestingly, the duration of residence of an intra-articular injection (days) cannot explain the prolonged clinical benefit (months), and accordingly, subsequent biologic mechanisms have been proposed that may play an important role in the clinical benefit. The combination of quadriceps strengthening and HAs may have a synergistic effect on pain.[66]
Viscosity can help to facilitate the cushioning and lubricating characteristics of the joint during slow movements, while elasticity blunts deforming forces (compression and resistance to shear forces) during rapid motions.
A study Waddell and colleagues hypothesized that hyaluronan inhibits interleukin-1beta–induced metalloproteinase production from osteoarthritic synovial tissue.[67]
As reviewed by Goldberg and Buckwalter, preclinical support is available for most of the HAs, as well as clinical evidence (particularly for Hyalgan) using arthroscopy, microscopy, and blinded morphologic assessments and weight-bearing radiographs for assessing joint-space narrowing.[20] Intra-articular HAs may also be chondroprotective early in the development of osteoarthritis. However, additional studies would seem to be warranted to further explore the ability of HAs to intervene in the disease processes associated with osteoarthritis. Certainly, a single product with symptomatic and disease-modifying characteristics, even if effective only in some patient populations, would be a valuable option in the management of knee osteoarthritis.
Electromagnetic field stimulation and TENS
A pulsed electromagnetic field stimulation device (Bionicare) has been FDA-approved for use in patients with knee osteoarthritis. Pulsed electromagnetic field stimulation is believed to act at the level of articular cartilage by maintaining proteoglycan composition of chondrocytes via down-regulation of its turnover.[68] One published multicenter, double-blind, randomized, placebo-controlled, 4-week trial, utilizing 78 patients with knee osteoarthritis, found improved pain and function in patients who were treated with the device.[69] Another randomized clinical trial demonstrated that pulsed shortwave treatment was effective in relieving pain and improving function and quality of life in women with knee osteoarthritis, on a short-term basis. Additional studies are needed to validate the 12-month follow-up.[70]
Transcutaneous electrical nerve stimulation (TENS) may be another treatment option for pain relief, but so far there exists only limited evidence that this modality is beneficial.[71]
Acupuncture
Acupuncture is becoming a more frequently used option in treating pain and physical dysfunction associated with osteoarthritis. Some evidence supports its use. For example, a significant decrease in pain after acupuncture, in comparison with the amount of pain persisting after control treatments, was reported in a review article of randomized, controlled trials.[72]
Arthroscopy
A procedure of low invasiveness and morbidity, arthroscopy will not interfere with future surgery. It may help patients with osteoarthritis of the knee in whom imaging reveals specific structural damage. Arthroscopy is especially indicated for removal of meniscal tears and loose bodies.[1]
Less predictable arthroscopic procedures include debridement of loose articular cartilage with a microfracture technique and cartilaginous implants in areas of eburnated subchondral bone. These treatments have varying success rates and should be performed only by surgeons experienced with arthroscopic surgical techniques.[1, 73, 74]
Arthroscopic views are shown in the images below.
Arthroscopic view of a torn meniscus before (top) and after (bottom) removal of loose meniscal fragments.
Arthroscopic view of an arthritic knee.
Arthroscopic view of a knee after the removal of loose fragments of articular and meniscal cartilage.
Arthroscopic view of the removal of cartilaginous loose body. A study by Kirkley et al found that arthroscopic surgery for osteoarthritis of the knee provided no additional benefit to patients who underwent optimized physical and medical therapy.[1] In an accompanying editorial, however, Marx stated that osteoarthritis is not a contraindication for arthroscopic surgery and that arthroscopic surgery remains appropriate, in specific situations, in patients with arthritis in whom osteoarthritis is not believed to be the primary cause of pain.[73, 74]
Overall, arthroscopy is not recommended for nonspecific "cleaning of the knee" in osteoarthritis.
Osteotomy
Consider osteotomy in patients with a malaligned hip or knee joint. The procedure is usually recommended in younger patients with osteoarthritis. Osteotomy can lessen pain, although it can lead to more challenging surgery later if the patient requires arthroplasty.
Osteotomy is used in active patients younger than 60 years who want to continue with reasonable physical activity.[75] The principle underlying this procedure is to shift weight from the damaged cartilage on the medial aspect of the knee to the healthy lateral aspect of the knee. Osteotomy is most beneficial for significant genu varum, or bowleg deformity. (The effectiveness of osteotomy for genu valgum is not highly predictable.) Osteotomy often can prevent individuals from requiring a total knee replacement until they are older.
Contraindications for osteotomy are knee flexion of less than 90°, a flexion-extension contracture of more than 15°, and a significant amount of varus over 15°-20°. Instability due to previous trauma or surgery, severe arterial insufficiency, and bicompartmental involvement are also contraindications.
Arthroplasty
Arthroplasty consists of the surgical removal of joint surface and the insertion of a metal and plastic prosthesis. The prosthesis is held in place by cement or by bone ingrowth into a porous coating on the prosthesis. The use of cement relieves pain more quickly, but bone ingrowth may last longer; therefore, prostheses with a porous coating are used in younger patients.
Perform arthroplasty if all other modalities are ineffective and osteotomy is not viable, or if a patient cannot perform his or her daily activities despite maximal therapy.[76, 77] This procedure alleviates pain and may improve function. Approximately 8-15 years of viability are expected from joint replacement in the absence of complications.
Examples of joint replacement are shown in the radiographs below.
Anteroposterior radiograph shows knee replacement in 1 knee and arthritis in the other, with medial joint-space narrowing and subchondral sclerosis.
Anteroposterior radiograph of the pelvis and hips shows an arthritic hip not treated surgically and a total hip replacement.
Anteroposterior radiograph obtained after knee replacement.
Lateral radiograph obtained after knee replacement (same patient as in the above image). Older procedures that were used in major joints are now used in small joints and in large joints in which there is extensive bone destruction and/or persistent infection.
Infection is a particular postsurgical concern in cases of total joint replacement. This complication is now rare, however, especially with the use of perioperative antibiotics.
The prevention of thrombophlebitis and resultant pulmonary embolism is important in patients who undergo lower extremity arthroplasty procedures for osteoarthritis. The surgeon must use all means available to prevent these complications, especially the initiation of early motion and ambulation when possible. The use of low-molecular-weight heparin or warfarin is also indicated.
For more information, see Total Knee Arthroplasty, Unicompartmental Knee Arthroplasty, Surgical Treatment of Patellofemoral Arthritis, and Surgical Treatment of Interphalangeal Joint Arthritis.
Resection arthroplasty
Resection arthroplasty consists of the removal of the joint and allowing the scar to separate the bones and to help in reducing pain. This procedure is sometimes used after the failure of hip replacements if there is extensive bone destruction or persistent infection.
Fusion
Fusion consists of the union of bones on either side of the joint. This procedure relieves pain but prevents motion and puts more stress on surrounding joints. Fusion is sometimes used after knee replacements fail or as a primary procedure for ankle or foot arthritis.
Joint lavage
Closed-needle joint lavage may benefit a small subgroup of patients with osteoarthritis.
Consultations
A physiatrist may help in formulating a nonpharmacologic management plan for the patient with osteoarthritis, and a nutritionist may help the patient to lose weight. A referral to an orthopedic surgeon may be necessary if the osteoarthritis fails to respond to a medical management plan.
Kirkley A, Birmingham TB, Litchfield RB, Giffin JR, Willits KR, Wong CJ, et al. A randomized trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. Sep 11 2008;359(11):1097-107. [Medline].
Kellgren JH. Osteoarthritis in patients and populations. Br Med J. 1961;Vol 2.:1-6.
Loughlin J. The genetic epidemiology of human primary osteoarthritis: current status. Expert Rev Mol Med. May 24 2005;7(9):1-12. [Medline].
Cheung EV, Adams R, Morrey BF. Primary osteoarthritis of the elbow: current treatment options. J Am Acad Orthop Surg. Feb 2008;16(2):77-87. [Medline].
Dagenais S, Garbedian S, Wai EK. Systematic review of the prevalence of radiographic primary hip osteoarthritis. Clin Orthop Relat Res. Mar 2009;467(3):623-37. [Medline]. [Full Text].
Lee P, Rooney PJ, Sturrock RD, Kennedy AC, Dick WC. The etiology and pathogenesis of osteoarthrosis: a review. Semin Arthritis Rheum. Spring 1974;3(3):189-218. [Medline].
Murray RO. The aetiology of primary osteoarthritis of the hip. Br J Radiol. Nov 1965;38(455):810-24. [Medline].
Radin ER, Paul IL, Rose RM. Pathogenesis of primary osteoarthritis. Lancet. Jun 24 1972;1(7765):1395-6. [Medline].
Sharma L. Epidemiology of osteoarthritis. In: Moskowitz RW, Howell DS, Altman, RD, et al, eds. Osteoarthritis. 3rd ed. 2001:3-27.
Veys E, Verbruggen G. Evolution and prognosis of osteoarthritis. In: Reginster JY, Pelletier JP, Martel-Pelletier J, et al, eds. Osteoarthritis. 1999:312-3.
Valderrabano V, Horisberger M, Russell I, Dougall H, Hintermann B. Etiology of ankle osteoarthritis. Clin Orthop Relat Res. Jul 2009;467(7):1800-6. [Medline]. [Full Text].
Buckland-Wright C, Verbruggen G, Haraoui PB. Imaging: radiological assessment of hand osteoarthritis. In: Osteoarthritis Cartilage. 2000:55-6.
Jewell FM, Watt I, Doherty M. Plain radiographic features of osteoarthritis. In: Brandt KD, Doherty M, Lohmander LS, eds. Osteoarthritis. New York, NY: Oxford University Press; 1998:217-37.
Mankin HJ. The reaction of articular cartilage to injury and osteoarthritis (first of two parts). N Engl J Med. Dec 12 1974;291(24):1285-92. [Medline].
Miller EJ, Van der Korst JK, Sokoloff L. Collagen of human articular and costal cartilage. Arthritis Rheum. Feb 1969;12(1):21-9. [Medline].
Phadke K. Regulation of metabolism of the chondrocytes in articular cartilage--an hypothesis. J Rheumatol. Dec 1983;10(6):852-60. [Medline].
Resnick D, Niwayama G. Degenerative disease of extraspinal locations. In: Resnick D, ed. Diagnosis of Bone and Joint Disorders. 3rd ed. 1995:1263-1371.
Poole AR. An introduction to the pathophysiology of osteoarthritis. Front Biosci. Oct 15 1999;4:D662-70. [Medline].
Radin EL, Paul IL. Response of joints to impact loading. I. In vitro wear. Arthritis Rheum. May-Jun 1971;14(3):356-62. [Medline].
Burkitt HG, Stevens A, Lowe JS. Skeletal system. In: Basic Histopathology. 3rd ed. New York, NY: Churchill Livingstone; 1996:260.
Hamerman D. The biology of osteoarthritis. N Engl J Med. May 18 1989;320(20):1322-30. [Medline].
Hartmann C, De Buyser J, Henry Y, Morère-Le Paven MC, Dyer TA, Rode A. Nuclear genes control changes in the organization of the mitochondrial genome in tissue cultures derived from immature embryos of wheat. Curr Genet. May 1992;21(6):515-20. [Medline].
Howell DS. Pathogenesis of osteoarthritis. Am J Med. Apr 28 1986;80(4B):24-8. [Medline].
Bullough PG. The geometry of diarthrodial joints, its physiologic maintenance, and the possible significance of age-related changes in geometry-to-load distribution and the development of osteoarthritis. Clin Orthop Relat Res. May 1981;61-6. [Medline].
Aigner T, Rose J, Martin J, Buckwalter J. Aging theories of primary osteoarthritis: from epidemiology to molecular biology. Rejuvenation Res. Summer 2004;7(2):134-45. [Medline].
OUTERBRIDGE RE. The etiology of chondromalacia patellae. J Bone Joint Surg Br. Nov 1961;43-B:752-7. [Medline].
Zgoda M, Paczek L, Bartlomiejczyk I, Sieminska J, Chmielewski D, Górecki A. Age-related decrease in the activity of collagenase in the femoral head in patients with hip osteoarthritis. Clin Rheumatol. Feb 2007;26(2):240-1. [Medline].
Felson DT. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev. 1988;10:1-28. [Medline].
Felson DT, Anderson JJ, Naimark A, Walker AM, Meenan RF. Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med. Jul 1 1988;109(1):18-24. [Medline].
Goulston LM, Kiran A, Javaid MK, et al. Does obesity predict knee pain over fourteen years in women, independently of radiographic changes?. Arthritis Care Res (Hoboken). Oct 2011;63(10):1398-406. [Medline].
Hurley MV. The role of muscle weakness in the pathogenesis of osteoarthritis. Rheum Dis Clin North Am. May 1999;25(2):283-98, vi. [Medline].
Felson DT. Risk factors for osteoarthritis: understanding joint vulnerability. Clin Orthop Relat Res. Oct 2004;S16-21. [Medline].
Hoaglund FT, Yau AC, Wong WL. Osteoarthritis of the hip and other joints in southern Chinese in Hong Kong. J Bone Joint Surg Am. Apr 1973;55(3):545-57. [Medline].
Roberts J, Burch TA. Osteoarthritis prevalence in adults by age, sex, race, and geographic area. Vital Health Stat 11. Jun 1966;1-27. [Medline].
Chapple CM, Nicholson H, Baxter GD, Abbott JH. Patient characteristics that predict progression of knee osteoarthritis: A systematic review of prognostic studies. Arthritis Care Res (Hoboken). Aug 2011;63(8):1115-25. [Medline].
[Guideline] Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum. Nov 1990;33(11):1601-10. [Medline].
[Guideline] Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. May 1991;34(5):505-14. [Medline].
[Guideline] Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. Aug 1986;29(8):1039-49. [Medline].
Brandt KD. A pessimistic view of serologic markers for diagnosis and management of osteoarthritis. Biochemical, immunologic and clinicopathologic barriers. J Rheumatol Suppl. Aug 1989;18:39-42. [Medline].
Recht MP, Kramer J, Marcelis S, Pathria MN, Trudell D, Haghighi P, et al. Abnormalities of articular cartilage in the knee: analysis of available MR techniques. Radiology. May 1993;187(2):473-8. [Medline].
Recht MP, Goodwin DW, Winalski CS, White LM. MRI of articular cartilage: revisiting current status and future directions. AJR Am J Roentgenol. Oct 2005;185(4):899-914. [Medline].
Jewell FM, Watt I, Doherty M. Plain radiographic features of osteoarthritis. In: Brandt KD, Doherty M, Lohmander LS, eds. Osteoarthritis. New York, NY: Oxford University Press; 1998:217-37.
Hunter DJ. Advanced imaging in osteoarthritis. Bull NYU Hosp Jt Dis. 2008;66(3):251-60. [Medline].
Keen HI, Wakefield RJ, Conaghan PG. A systematic review of ultrasonography in osteoarthritis. Ann Rheum Dis. May 2009;68(5):611-9. [Medline].
Kraus VB, McDaniel G, Worrell TW, Feng S, Vail TP, Varju G, et al. Association of bone scintigraphic abnormalities with knee malalignment and pain. Ann Rheum Dis. Nov 2009;68(11):1673-9. [Medline].
[Guideline] Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. Feb 2008;16(2):137-62. [Medline].
Felson DT, Zhang Y, Anthony JM, Naimark A, Anderson JJ. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study. Ann Intern Med. Apr 1 1992;116(7):535-9. [Medline].
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. Sep 2000;43(9):1905-15. [Medline].
Neustadt DH. Intra-articular therapy. In: Moskowitz RW, Howell DS, Altman RD, et al, eds. Osteoarthritis. 3rd ed. 2001:393-409.
Lineker SC, Bell MJ, Boyle J, Badley EM, Flakstad L, Fleming J, et al. Implementing arthritis clinical practice guidelines in primary care. Med Teach. Mar 2009;31(3):230-7. [Medline].
Godwin M, Dawes M. Intra-articular steroid injections for painful knees. Systematic review with meta-analysis. Can Fam Physician. Feb 2004;50:241-8. [Medline]. [Full Text].
Lambert RG, Hutchings EJ, Grace MG, Jhangri GS, Conner-Spady B, Maksymowych WP. Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. Jul 2007;56(7):2278-87. [Medline].
Hathcock JN, Shao A. Risk assessment for glucosamine and chondroitin sulfate. Regul Toxicol Pharmacol. Feb 2007;47(1):78-83. [Medline].
Roddy E, Doherty M. Changing life-styles and osteoarthritis: what is the evidence?. Best Pract Res Clin Rheumatol. Feb 2006;20(1):81-97. [Medline].
Perrot S, Poiraudeau S, Kabir M, Bertin P, Sichere P, Serrie A, et al. Active or passive pain coping strategies in hip and knee osteoarthritis? Results of a national survey of 4,719 patients in a primary care setting. Arthritis Rheum. Nov 15 2008;59(11):1555-62. [Medline].
Anandacoomarasamy A, Leibman S, Smith G, et al. Weight loss in obese people has structure-modifying effects on medial but not on lateral knee articular cartilage. Ann Rheum Dis. Jan 2012;71(1):26-32. [Medline].
McCarthy GM, McCarty DJ. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J Rheumatol. Apr 1992;19(4):604-7. [Medline].
[Best Evidence] Jan MH, Lin CH, Lin YF, Lin JJ, Lin DH. Effects of weight-bearing versus nonweight-bearing exercise on function, walking speed, and position sense in participants with knee osteoarthritis: a randomized controlled trial. Arch Phys Med Rehabil. Jun 2009;90(6):897-904. [Medline].
[Best Evidence] Chaipinyo K, Karoonsupcharoen O. No difference between home-based strength training and home-based balance training on pain in patients with knee osteoarthritis: a randomised trial. Aust J Physiother. 2009;55(1):25-30. [Medline].
[Best Evidence] Wang C, Schmid CH, Hibberd PL, Kalish R, Roubenoff R, Rones R, et al. Tai Chi is effective in treating knee osteoarthritis: a randomized controlled trial. Arthritis Rheum. Nov 15 2009;61(11):1545-53. [Medline].
Marks R, Allegrante JP. Chronic osteoarthritis and adherence to exercise: a review of the literature. J Aging Phys Act. Oct 2005;13(4):434-60. [Medline].
Goldberg VM, Buckwalter JA. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cartilage. Mar 2005;13(3):216-24. [Medline].
Stitik TP, Levy JA. Viscosupplementation (biosupplementation) for osteoarthritis. Am J Phys Med Rehabil. Nov 2006;85(11 Suppl):S32-50. [Medline].
Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. Apr 19 2006;CD005321. [Medline].
Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol. Nov 1998;25(11):2203-12. [Medline].
Stitik TP, Blacksin MF, Stiskal DM, Kim JH, Foye PM, Schoenherr L, et al. Efficacy and safety of hyaluronan treatment in combination therapy with home exercise for knee osteoarthritis pain. Arch Phys Med Rehabil. Feb 2007;88(2):135-41. [Medline].
Waddell DD, Kolomytkin OV, Dunn S, Marino AA. Hyaluronan suppresses IL-1beta-induced metalloproteinase activity from synovial tissue. Clin Orthop Relat Res. Dec 2007;465:241-8. [Medline].
Liu H, Abbott J, Bee JA. Pulsed electromagnetic fields influence hyaline cartilage extracellular matrix composition without affecting molecular structure. Osteoarthritis Cartilage. Mar 1996;4(1):63-76. [Medline].
Zizic TM, Hoffman KC, Holt PA, Hungerford DS, O'Dell JR, Jacobs MA, et al. The treatment of osteoarthritis of the knee with pulsed electrical stimulation. J Rheumatol. Sep 1995;22(9):1757-61. [Medline].
Fukuda TY, Alves da Cunha R, Fukuda VO, et al. Pulsed shortwave treatment in women with knee osteoarthritis: a multicenter, randomized, placebo-controlled clinical trial. Phys Ther. Jul 2011;91(7):1009-17. [Medline].
Ying KN, While A. Pain relief in osteoarthritis and rheumatoid arthritis: TENS. Br J Community Nurs. Aug 2007;12(8):364-71. [Medline].
Selfe TK, Taylor AG. Acupuncture and osteoarthritis of the knee: a review of randomized, controlled trials. Fam Community Health. Jul-Sep 2008;31(3):247-54. [Medline]. [Full Text].
Marx RG. Arthroscopic Surgery for Osteoarthritis of the Knee?. New England Journal of Medicine. 2008;Vol. 359:1169-1170. [Full Text].
Barclay L, Nghiem HT. Arthroscopic Surgery May Not Be Helpful for Knee Osteoarthritis. Medscape. Available at http://www.medscape.com/viewarticle/580300. Accessed September 29, 2010.
Pagenstert G, Knupp M, Valderrabano V, Hintermann B. Realignment surgery for valgus ankle osteoarthritis. Oper Orthop Traumatol. Mar 2009;21(1):77-87. [Medline].
Daras M, Macaulay W. Total hip arthroplasty in young patients with osteoarthritis. Am J Orthop (Belle Mead NJ). Mar 2009;38(3):125-9. [Medline].
Kuo A, Ezzet KA, Patil S, Colwell CW Jr. Total hip arthroplasty in rapidly destructive osteoarthritis of the hip: a case series. HSS J. Sep 2009;5(2):117-9. [Medline]. [Full Text].
Miller M, Stürmer T, Azrael D, Levin R, Solomon DH. Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc. Mar 2011;59(3):430-8. [Medline].
Belhorn LR, Hess EV. Erosive osteoarthritis. Semin Arthritis Rheum. Apr 1993;22(5):298-306. [Medline].
Kellgren JH, Moore R. Generalized osteoarthritis and Heberden's nodes. Br Med J. 1952;Vol 1:181-7.
Zanetti M, Bruder E, Romero J, Hodler J. Bone marrow edema pattern in osteoarthritic knees: correlation between MR imaging and histologic findings. Radiology. Jun 2000;215(3):835-40. [Medline].

